Condition: Bacterial Vaginosis · Vulvovaginal Candidiasis · Sponsor: Queen's Medical Center
This project aims to investigate if the contraceptive method, Phexxi, causes changes to the composition of the vaginal microbiome. The investigators hypothesize that regular use of Phexxi will cause increased colonization of lactic acid-producing lactobacilli, which could have positive effects in the way of preventing recurrent episodes of BV and candida infections.
This description comes directly from the study's public registry record.
Olivia H Manayan, MD, MPH · 808-348-7859 · omanayan@hawaii.edu
Always discuss trial participation with your own doctor first.
| Queens Medical Center, 1004 Clinic POB1 | Honolulu, Hawaii, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05753813